Skip to main content
. 2021 Jun 27;13(6):634–649. doi: 10.4254/wjh.v13.i6.634

Table 4.

Monitoring urinary copper excretion in the treatment of Wilson’s disease

Treatment
Initial treatment
Maintenance treatment
Undertreatment or non-compliance
Overtreatment or non-compliance
D penicillamine > 500 μg/24 h 200-500 μg/24 h > 500 μg/24 h < 200 μg/24 h
Trientine > 500 μg/24 h 200-500 μg/24 h > 500 μg/24 h < 100 μg/24 h
Zinc > 100-500 μg/24 h < 75 μg/24 h > 15 μg/24 h < 5 μg/24 h